Muscle transplantation in the aetiological elucidation of murine muscular dystrophy

Receptor-mediated targeting of a photosensitizer by its conjugation to gonadotropin-releasing hormone analogues

Photodynamic therapy uses a combination of light, oxygen, and a photosensitizer to induce the death of malignant cells. To improve the selectivity of a photosensitizer toward cancerous cells that express gonadotropin-releasing hormone (GnRH) receptors, protoporphyrin IX (PpIX) was conjugated to a GnRH agonist, [d-Lys6]GnRH, or to a GnRH antagonist, [d-pGlu1, d-Phe2, d-Trp3, d-Lys6]GnRH. The condensation of the peptide with PpIX was carried out in a homogeneous solution using benzotriazole-1-yloxytris(pyrrolidinophosphonium) hexafluorophosphate as a coupling reagent. Although these conjugates had lower binding affinity to rat pituitary GnRH receptors than their parent analogues, they fully preserved their agonistic or antagonistic activity in vitro and in vivo. The GnRH agonist conjugate proved to be long-acting in vivo. Thus, 24 h after its administration to rats (2 nmol/rat), serum LH concentrations were significantly higher than in rats treated with the same amount of the parent peptide. The conjugates, notably the agonist, were more phototoxic toward pituitary gonadotrope alphaT3-1 cell line than was unconjugated PpIX. In contrast to PpIX, the phototoxicity of the conjugates toward alphaT3-1 cells or to human breast cancer cells (MCF-7 cells that were transfected with human GnRH receptors) was alleviated by co-incubation with the parent peptide, indicating that phototoxicity is receptor-mediated. The selectivity of the GnRH antagonist conjugate to gonadotrope cells in a primary pituitary culture was approximately 10 times higher than that of the unconjugated PpIX. Thus, GnRH-based conjugates may affect cancer cells not only by acting as classic GnRH analogues to reduce the plasma levels of steroids by desensitization of the pituitary gland but also by selective photodamage of cells that express GnRH receptors.

Modification of the phenotypic expression of murine dystrophy: a morphological study

The extensor digitorum longus muscles of 4-6-week-old normal mice (129 ReJ) and dystrophic mice (129 ReJ dy/dy) were orthotopically transplanted. Grafted muscles were examined 1, 3, 7, 14, 20, 50, and 100 days post-transplantation. The myofibers of both types of grafts underwent a similar time course of necrosis and regeneration. Other than during the initial necrotic response, no evidence of necrotic myofibers was found in either type of grafted muscle. At 100 days post-transplantation, the grafted normal and dystrophic muscles were essentially similar, except that the dystrophic graft was of smaller size. Based on a comparison of the number of myofibers found at the 100-day grafts' widest girths [631 +/- 59 SEM, for normal grafts (Bourke and Ontell, 1984); 631 +/- 74 SEM, for dystrophic grafts], it is suggested that the regenerative capability of traumatized 4-6-week-old dystrophic muscle is similar to that of traumatized normal muscle. At 100 days post-transplantation, the grafted dystrophic muscle appeared "healthier" than untraumatized muscle from age-matched dystrophic mice, having less variation in myofiber diameter, better fascicular organization, and less connective tissue. The transplantation system demonstrates the possibility of modifying the expression of genetic programming of myopathic disorders using environmental manipulation.

A possible mechanism of phenotypic expression of normal and dystrophic genomes on succinic dehydrogenase activity and fiber size within a single myofiber of muscle transplants

Muscle transplantation was used to evaluate the ability of normal and dystrophic chickens to support regeneration of both normal and dystrophic muscle fragments. Pectoralis muscles were grafted into the site of the biceps muscle of host chickens. Identification of dystrophic characteristics of intact and regenerating muscle fibers was made by cytochemical analysis of mitochondrial succinic dehydrogenase (SDH) and by fiber size. In the biceps muscle of dystrophic chicks at 40 days ex ovo, the mean size of muscle fibers with low activity of SDH and fibers with high SDH activity was 29.0 +/- 5.9 micrometers and 42.0 +/- 10.4 micrometers, respectively. The mean size of normal muscle fibers was notably smaller than in dystrophic muscle and was 17.8 + 3.1 micrometers. The hypertrophy of fibers coupled with elevation of SDH activity tended to increase with age. Transplants were examined at 56 days postoperatively. The results of cross-transplantation between normal and dystrophic genotypes were similar to unoperated muscles in the correlation between SDH activity and fiber size. Donor muscles determined the type of myofibers regenerated in transplants regardless of whether the host was normal or dystrophic. In addition, combined transplantation was attempted to produce a single hybrid myofiber in which normal and dystrophic pectoralis muscle were mixed in equal volume. The mixtures were then allowed to regenerate in host chicks. A number of mosaic myofibers appeared in transplants and had regional differences in SDH activity along their length. It was concluded that: (1) The characteristics of high SDH activity and fiber hypertrophy are an expression of dystrophic nuclei, (2) combined transplantation of both normal and dystrophic muscle fragments can produce mosaic myofibers in SDH reaction; and (3) the local control of SDH activity and fiber size within nuclear territories in mosaic myofibers seems likely to be due to phenotypic expression of either normal or dystrophic genomes.

Abnormalities of the sciatic nerves of dystrophic mice with reference to the large U-axons

A statistical study using regression analysis was used to evaluate the density of axonal organelles in dystrophic peripheral nerves. The slope of the density of neurotubules (NT) in myelinated (M-) axons was different from that in small unmyelinated (U-) axons. The slope of the density of NT in large U-axons (larger than 1.5 micron in diameter) was similar to that of the M-axons in both the dystrophic and control mice. There was a higher density of NT in the dystrophic M-axons than in the controls in the anterior, posterior and mixed nerves of the sciatic nerve. There was also a higher density of NT in the dystrophic small U-axons than in the controls. There was a higher density of neurofilaments (NF) of M-axons in the dystrophic mice than in the controls. On the contrary, the NF of small U-axons were lower in density in the dystrophic mice. These results were different from our previous reports, which were observed in the distal part, depending on when the groups of U-axons were divided (Okada, Mizuhira and Nakamura 1976a).

Dysmyelination in the sciatic nerves of dystrophic mice

Ultrastructural alterations were observed in the sciatic nerve of dystrophic mice. Myelin sheaths were abnormal in shape, abruptly ceased beyond a node of Ranvier, leaving the axon naked. These changes were seen in both afferent and efferent nerve fibres. Apparent embryonal Schwann cells and Schwann cells which were associated with increased lysosomes in the cytoplasm were observed in the proximal portion. There is a relative decrease in Schwann cells in the cross-section of the radicular parts, and a relative increase in the distal parts. The mean number of neurotubules per unit area was smaller while the mean number of the neurofilaments was larger in U-axons, in the dystrophic mice than in the controls. In M-fibres, neurotubules and neurofilaments showed no significant difference between systrophic and control mice.

Dystrophic spinal cord transplants induce abnormal thymidine kinase activity in normal muscles

The role of the neural tube in the pathogenesis of muscular dystrophy was tested directly. Neural tubes from chicken embryos with hereditary muscular dystrophy and from genetically normal embryos were transplanted into normal recipient embryos. Dystrophic neural tissue induced in muscles of normal hosts high thymidine kinase activity characteristic of dystrophic muscle; normal neural tubes did not. We propose an early inductive effect of the neural tube on the presumptive myoblasts that sets their subsequent course of development, either normal or dystrophic.

Neural abnormalities in the dystrophic mouse

Neural abnormalities (area of amyelination) have been found in the cranial nerves and in the ventral cervical and lumbosacral roots and in the mixed spinal nerves of bar harbor dystrophic mice of both the severe (129 Re/J dy/dy) and benign (dy-2J DY-2J) forms. The significance of these findings is discussed.

Neurogenic control of muscle ribosomal protein synthesis

In vitro protein synthesis of ribosomes extracted from leg muscles of 20 Sprague-Dawley rats denervated 3 and 14 days (high sciatic transections) and 10 control rats was studied. The concentration/mg protein of total ribosomes extracted from the 14-day denervated muscle showed a significant increase. Distribution of muscle polyribosomes on sucrose density gradients was normal in all cases. Noncollagen protein synthesis of the heavy polyribosomes from both early and late denervated muscles showed a significant decrease. SDS polyacrylamide gels suggested that this decrease affected the synthesis of heavy chains of myosin, while the light chains of myosin, actin and tropomyosin had normal structure and amounts. Collagen synthesis of heavy polyribosomes showed slight to moderate increase in only 50 per cent of the cases. Supplementation of ribosomes extracted from denervated muscles with normal muscle soluble enzymes increased their noncollagen synthesis by 66 per cent. This suggests that the neurogenic control of ribosomal protein synthesis is accomplished by hormonal trophic substances contained in the muscle soluble enzymes.

A neurogenic component in muscular dystrophy

Evidence for a neurogenic component in mouse and human muscular dystrophy is briefly reviewed. Such evidence comes from certain clinical observations, electrophysiological studies, muscle pathology, nervous system pathology, transplantation experiments in animals, and tissue culture studies. The evidence is at present rather conflicting though the results of recent tissue culture experiments are more convincing. If there is a neurogenic component in dystrophy then the basic defect may have to be sought in the central nervous system rather than in the muscle itself. It is argued, however, that a neurogenic component in dystrophy cannot be simply a defect in the anterior horn cells of the spinal cord since the clinical features and the laboratory and pathological findings are quite different from those in spinal muscular atrophy.